Biomarker Analysis from the Compass Claudication Study - Rivaroxaban for Intermittent Claudication. - Britto KF; Caffaro RA; Volpiani GG; Portugal MF; Neves S; Paganotti A; Pereira FM; Agati LB; Ribeiro CM; da Silva VS; Krupa E; Tavares IR; et al. (Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2025)